194 related articles for article (PubMed ID: 37387205)
1. Percutaneous approach for reducing outflow tract obstruction in hypertrophic obstructive cardiomyopathy.
Ojha U; Parikh M; Patel V
Future Cardiol; 2023 Mar; 19(4):203-210. PubMed ID: 37387205
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic management of hypertrophic obstructive cardiomyopathy: alcohol septal ablation or surgical myomectomy?
Noble S; Sigwart U
Expert Rev Cardiovasc Ther; 2014 Sep; 12(9):1041-4. PubMed ID: 25039895
[TBL] [Abstract][Full Text] [Related]
3. A novel approach in the use of radiofrequency catheter ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy.
Shelke AB; Menon R; Kapadiya A; Yalagudri S; Saggu D; Nair S; Narasimhan C
Indian Heart J; 2016; 68(5):618-623. PubMed ID: 27773399
[TBL] [Abstract][Full Text] [Related]
4. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.
Veselka J
Med Sci Monit; 2007 Apr; 13(4):RA62-8. PubMed ID: 17392660
[TBL] [Abstract][Full Text] [Related]
5. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
Valeti US; Nishimura RA; Holmes DR; Araoz PA; Glockner JF; Breen JF; Ommen SR; Gersh BJ; Tajik AJ; Rihal CS; Schaff HV; Maron BJ
J Am Coll Cardiol; 2007 Jan; 49(3):350-7. PubMed ID: 17239717
[TBL] [Abstract][Full Text] [Related]
6. Radiofrequency ablation of the interventricular septum to treat outflow tract gradients in hypertrophic obstructive cardiomyopathy: a novel use of CARTOSound® technology to guide ablation.
Cooper RM; Shahzad A; Hasleton J; Digiovanni J; Hall MC; Todd DM; Modi S; Stables RH
Europace; 2016 Jan; 18(1):113-20. PubMed ID: 26541709
[TBL] [Abstract][Full Text] [Related]
7. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort.
Nguyen A; Schaff HV; Hang D; Nishimura RA; Geske JB; Dearani JA; Lahr BD; Ommen SR
J Thorac Cardiovasc Surg; 2019 Jan; 157(1):306-315.e3. PubMed ID: 30279000
[TBL] [Abstract][Full Text] [Related]
8. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation: A useful tool in our arsenal against hypertrophic obstructive cardiomyopathy.
Savarimuthu S; Harky A
J Card Surg; 2020 Aug; 35(8):2017-2024. PubMed ID: 32652778
[TBL] [Abstract][Full Text] [Related]
10. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Will there ever be a randomized trial?
Olivotto I; Ommen SR; Maron MS; Cecchi F; Maron BJ
J Am Coll Cardiol; 2007 Aug; 50(9):831-4. PubMed ID: 17719467
[TBL] [Abstract][Full Text] [Related]
11. Successful percutaneous transluminal septal myocardial ablation through a right superior septal artery for a patient with hypertrophic obstructive cardiomyopathy.
Kurita T; Tsuchikane E; Tanaka N; Suzuki T
Cardiovasc Interv Ther; 2015 Oct; 30(4):377-81. PubMed ID: 25502014
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy].
Liu LW; Zuo L; Zhou MY; Li J; Zhou XD; He GB; Zhang J; Zhang JZ; Liu B; Yang J; Xu B
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Apr; 47(4):284-290. PubMed ID: 31060187
[No Abstract] [Full Text] [Related]
13. Radiofrequency septal reduction in symptomatic hypertrophic obstructive cardiomyopathy.
Crossen K; Jones M; Erikson C
Heart Rhythm; 2016 Sep; 13(9):1885-90. PubMed ID: 27132152
[TBL] [Abstract][Full Text] [Related]
14. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis.
Zeng Z; Wang F; Dou X; Zhang S; Pu J
Int J Cardiol; 2006 Sep; 112(1):80-4. PubMed ID: 16507323
[TBL] [Abstract][Full Text] [Related]
15. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre.
Bhagwandeen R; Woo A; Ross J; Wigle ED; Rakowski H; Kwinter J; Eriksson MJ; Schwartz L
Can J Cardiol; 2003 Jul; 19(8):912-7. PubMed ID: 12876612
[TBL] [Abstract][Full Text] [Related]
16. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; Grübbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
17. The effects of septal myectomy and alcohol septal ablation for hypertrophic cardiomyopathy on the cardiac conduction system.
Fitzgerald P; Kusumoto F
J Interv Card Electrophysiol; 2018 Aug; 52(3):403-408. PubMed ID: 30097789
[TBL] [Abstract][Full Text] [Related]
18. Extended septal myectomy and left ventricular outflow tract intervention for hypertrophic obstructive cardiomyopathy.
Pruna-Guillen R; Ascaso M; Affronti A; Quintana E
Multimed Man Cardiothorac Surg; 2021 Mar; 2021():. PubMed ID: 33691043
[TBL] [Abstract][Full Text] [Related]
19. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous alcohol septal ablation following surgical myectomy.
Jaradat ZA; Sayfo SM; Breall JA
J Invasive Cardiol; 2010 Aug; 22(8):E147-9. PubMed ID: 20679680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
